TAILIEUCHUNG - CLINICAL OCULAR PHARMACOLOGY, FIFTH EDITION

There continues to be an explosion of research on issues of pharmacologic relevance to primary eye care delivery. New ophthalmic formulations are being developed, new diagnostic methods introduced,and new medications and delivery systems are available that were unheard of a decade ago. It is important that these new concepts be introduced to students and practitioners alike. This new fifth edition of Clinical Ocular Pharmacology addresses these new concepts and provides “one-stop shopping”for students, residents, and practicing clinicians who need a ready source of information regarding both the basic pharmacology of ophthalmic drugs, as well as their utilization in clinical practice. In this edition, readers will find that every chapter has been substantially updated. | JIMMY D. BARTLETT SIRET D. JAANUS CLINICAL ỌỘỊÌỊẠR PHARMACOLOGY SECTION EDITORS. RICHARD A NICKY R HOLOEMAN C. LISA PROKOPICH BUTTERWORTH HEINEMANN ELSEVIER 11830 Westline Industrial Drive St. Louis Missouri 63146 CLINICAL OCULAR PHARMACOLOGY FIFTH EDITION ISBN 978-0-7506-7576-5 Copyright 2008 by Butterworth-Heinemann an imprint of Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means electronic or mechanical including photocopying recording or any information storage and retrieval system without permission in writing from the publisher. Permissions may be sought directly from Elsevier s Rights Department phone 1 215 239 3804 US or 44 1865 843830 UK fax 44 1865 853333 e-mail healthpermissions@ may also complete your request online via the Elsevier website at http permissions. Notice Knowledge and best practice in this field are constantly changing. As new research and experience broaden our knowledge changes in practice treatment and drug therapy may become necessary or appropriate. Readers are advised to check the most current information provided i on procedures featured or ii by the manufacturer of each product to be administered to verify the recommended dose or formula the method and duration of administration and contraindications. It is the responsibility of the practitioner relying on their own experience and knowledge of the patient to make diagnoses to determine dosages and the best treatment for each individual patient and to take all appropriate safety the fullest extent of the law neither the Publisher nor the Editors assume any liability for any injury and or damage to persons or property arising out of or related to any use of the material contained in this book. The Publisher Library of Congress Control Number 2007932736 Vice President and Publisher Linda Duncan Senior Editor Kathy Falk Senior Developmental Editor .

TỪ KHÓA LIÊN QUAN
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.